The Effects of Urtica dioica (Nettle) and Vaccinium myrtillus (European Blueberry) on Blood Glucose Parameters and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial
International Journal of Drug Research in Clinics · 2023
DOI: 10.34172/ijdrc.2023.e5 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Drug Research in Clinics, 2023. Verfasst von Anita Chehri und 7 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Diabetes mellitus (DM), and more specifically type 2 DM (T2DM), is a growing metabolic disease and is accompanied by changes in lipid profile and glycemic parameters which contribute to debilitating complications. Nettle and European blueberry as complementary herbal medicine could play a significant role in managing elevated levels of blood sugar and diabetic complications. The goal of this study was to determine the effects of nettle and European blueberry combination as adjunct therapy in patients with T2DM.
Methods
The randomized double-blind clinical trial included 59 T2D patients with a mean age of 57.9 years. Participants were randomly assigned to two groups to take either nettle-bilberry capsules (500/mg/dose twice a day, n=29) or a placebo (n=30) for three months. Fasting blood samples were obtained at the beginning and after the intervention to quantify 15 items, including lipid profile and glycemic factors.
Results
Sixty patients were enrolled in this study. The groups had no significant difference regarding the demographics and the study variables at the baseline. Compared with the placebo, the nettle-bilberry combination resulted in significant decreases in fasting blood sugar (FBS), triglyceride, cholesterol, and low-density lipoprotein (LDL) levels (P0.05).
Conclusion
Overall, a combination of nettle and bilberry had beneficial impacts on the levels of FBS, cholesterol, and LDL. However, this combination had no significant effects on the other glycemic factors and lipid profile indicators. Trial Registration: This study was a double-blind randomized controlled trial study that was registered in the Iranian Registry of Clinical Trials (IRCT: IRCT20140617018126N3). In addition, approval was obtained from the Ethics Committee of Tabriz University of Medical Sciences (Ethics code: IR.TBZMED.REC.1399.093).
Zitieren
APA
Chehri, A., Yarani, R., Yousefi, Z., Shakouri, S. K., Ostadrahimi, A., Mobasseri, M., Majidazar, R., & Araj-khodaei, M. (2023). The Effects of Urtica dioica (Nettle) and Vaccinium myrtillus (European Blueberry) on Blood Glucose Parameters and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial. International Journal of Drug Research in Clinics. https://doi.org/10.34172/ijdrc.2023.e5
Vancouver
Chehri A, Yarani R, Yousefi Z, Shakouri SK, Ostadrahimi A, Mobasseri M, et al. The Effects of Urtica dioica (Nettle) and Vaccinium myrtillus (European Blueberry) on Blood Glucose Parameters and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial. International Journal of Drug Research in Clinics. 2023. doi:10.34172/ijdrc.2023.e5
BibTeX
@article{Chehri2023,
author = {Chehri, Anita and Yarani, Reza and Yousefi, Zahra and Shakouri, Seyed Kazem and Ostadrahimi, Alireza and Mobasseri, Majid and Majidazar, Reza and Araj-khodaei, Mostafa},
title = {The Effects of Urtica dioica (Nettle) and Vaccinium myrtillus (European Blueberry) on Blood Glucose Parameters and Lipid Profile in Patients With Type 2 Diabetes Mellitus: A Double-Blind Randomized Controlled Trial},
journal = {International Journal of Drug Research in Clinics},
year = {2023},
doi = {10.34172/ijdrc.2023.e5}
}
EUVIMED